Margo Heath‐Chiozzi
Celldex Therapeutics (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, Urticaria and Related Conditions, Mast cells and histamine
Most-Cited Works
- → Clinical application of pharmacogenetics(2001)642 cited
- → Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease(1998)541 cited
- → The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir(1998)224 cited
- → The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses(1999)182 cited
- → Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen(2000)152 cited
- → Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria(2022)114 cited
- → Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End Points(1999)107 cited
- → A Phase I/II Study of the Protease Inhibitor Ritonavir in Children With Human Immunodeficiency Virus Infection(1998)94 cited
- → Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C(2014)84 cited
- → Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study(2022)71 cited